Komori
Pharma Foods International (2929) · FactAdvanced

Market transfer from Tokyo Stock Exchange Mothers to the Second Section

First written in FY2017-Q1. 2 of 5 entries say "Restated". Latest entry: FY2022-Q3.

5entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017-Q1 – FY2017-Q2RestatedFY2021-Q32016: 12017: 120172018: 020182019: 020192020: 020202021: 220212022: 12022
Same theme, other companies

The whole theme swung hardest in 2022: 20 of 43 companies on the "Worse" side.

3 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 48 companies compared. The sentences above are computed from all 48.
Full recordFilings, disclosures and news, newest first
  1. FY2022-Q3AdvancedAnnual report

    「The company was listed on the First Section of the Tokyo Stock Exchange, but following the Tokyo Stock Exchange’s review of its market segments effective 4 April 2022, the listing exchange and market have been the Tokyo Stock Exchange Prime Market since that date.」

    The transition from the First Section of the Tokyo Stock Exchange to the Prime Market is being reconfirmed.
  2. FY2021-Q3RestatedAnnual report

    「Effective 12 February 2021, the company’s listing was changed from the Second Section of the Tokyo Stock Exchange to the First Section of the same exchange.」

    The change of listing to the First Section of the Tokyo Stock Exchange is being reconfirmed.
  3. FY2021-Q2AdvancedAnnual report

    「Effective 12 February 2021, the company’s listing was changed from the Second Section of the Tokyo Stock Exchange to the First Section of the same exchange.」

    Following the change to the Second Section in 2016, the company’s listing was changed to the First Section of the Tokyo Stock Exchange effective 12 February 2021.
  4. FY2017-Q2RestatedAnnual report

    「In addition, on 1 December 2016, the listing market changed to the Second Section of the Tokyo Stock Exchange based on the Company's choice of listing market after 10 years of listing on the Tokyo Stock Exchange Mothers market.」

    The change of listing to the Second Section of the Tokyo Stock Exchange effective 1 December 2016 is being restated.
  5. FY2017-Q1First statedAnnual report

    「Effective 1 December 2016, the Company's shares changed markets from the Tokyo Stock Exchange Mothers market to the Second Section of the Tokyo Stock Exchange.」

    On 1 December 2016, the listing market changed from Mothers to the Second Section of the Tokyo Stock Exchange.
Moved together

"Commercialization and Development Pipeline for New Functional Materials" moved the same way as this thread, in the same document, in 2 of its 5 moves.

222222★123456
  1. ★This thread
  2. 1Commercialization and Development Pipeline for New Functional Materials2×
  3. 2Development of antibody therapeutics using proprietary chicken antibody technology2×
  4. 3Aggressive business investment aimed at sustained long-term growth and increased corporate value2×
  5. 4Advertising Investment and Product Brand Expansion in Mail-Order Sales2×
  6. 5Functional Materials business: lower revenue and profit2×
  7. 6Raising Working Capital through Borrowings2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Pharma Foods International yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.